| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |